KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Medtronic (MDT) EBIAT (2016 - 2026)

Medtronic's EBIAT history spans 13 years, with the latest figure at $1.2 billion for Q1 2026.

  • For Q1 2026, EBIAT fell 10.09% year-over-year to $1.2 billion; the TTM value through Jan 2026 reached $4.7 billion, up 9.33%, while the annual FY2025 figure was $4.7 billion, 27.61% up from the prior year.
  • EBIAT for Q1 2026 was $1.2 billion at Medtronic, down from $1.4 billion in the prior quarter.
  • Across five years, EBIAT topped out at $1.5 billion in Q1 2022 and bottomed at $435.0 million in Q4 2022.
  • The 5-year median for EBIAT is $1.2 billion (2026), against an average of $1.1 billion.
  • The largest annual shift saw EBIAT tumbled 66.97% in 2022 before it soared 109.43% in 2023.
  • A 5-year view of EBIAT shows it stood at $435.0 million in 2022, then skyrocketed by 109.43% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then grew by 8.06% to $1.4 billion in 2025, then fell by 16.73% to $1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's EBIAT are $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.0 billion (Q3 2025).